NEW YORK (GenomeWeb News) – Ohio State University will partner with the Coriell Institute for Medical Research in a personalized medicine study that will enroll 2,000 participants from OSU Medical Center.
OSU said today that it has joined Coriell Personalized Medicine Collaborative, which involves four other participating centers, including Fox Chase Cancer Center, Cooper University Hospital, Virtua Health, and Helix Health.
The Coriell collaboration involves doctors, patients, geneticists, counselors, and IT experts working together to create "a protected environment for participants to see and understand their personal genomic information, and allow them to make individualized decisions about their health care," OSU said.
"Through this collaboration, we will provide the unique opportunity for our community to participate in this ground-breaking national study and move toward wellness-based care that is predictive, preventive, personalized and participatory," Clay Marsh, who is director of OSU's Center for Personalized Health Care, said in a statement.